NPPA not to stop withdrawal of stents from market

NEW DELHI: Drug price regulator NPPA today said it has decided not to stop any coronary stent manufacturer from withdrawing products from the Indian market. The National Pharmaceutical Pricing Authority (NPPA) said however that the companies will have to follow mandatory requirement of informing it six months in advance as prescribed under Drugs Prices Control Order (DPCO), 2013, while also following the ceiling price.

Read More